Hostname: page-component-8448b6f56d-c47g7 Total loading time: 0 Render date: 2024-04-19T14:41:10.659Z Has data issue: false hasContentIssue false

Low compliance with recommendations on folic acid use in relation to pregnancy: is there a need for fortification?

Published online by Cambridge University Press:  02 January 2007

Vibeke K Knudsen*
Affiliation:
Maternal Nutrition Group, Danish Epidemiology Science Centre, Statens Serum Institut, 5 Artillerivej, DK-2300, Copenhagen S, Denmark
Ivanka Orozova-Bekkevold
Affiliation:
Maternal Nutrition Group, Danish Epidemiology Science Centre, Statens Serum Institut, 5 Artillerivej, DK-2300, Copenhagen S, Denmark
Lone B Rasmussen
Affiliation:
Danish Veterinary and Food Administration, Institute of Food Safety and Nutrition, Søborg, Denmark
Tina B Mikkelsen
Affiliation:
Maternal Nutrition Group, Danish Epidemiology Science Centre, Statens Serum Institut, 5 Artillerivej, DK-2300, Copenhagen S, Denmark
Kim F Michaelsen
Affiliation:
Department of Human Nutrition, Royal Veterinary and Agricultural University, Copenhagen, Denmark Danish National Nutrition Council, Copenhagen, Denmark
Sjúrður F Olsen
Affiliation:
Maternal Nutrition Group, Danish Epidemiology Science Centre, Statens Serum Institut, 5 Artillerivej, DK-2300, Copenhagen S, Denmark Danish Veterinary and Food Administration, Institute of Food Safety and Nutrition, Søborg, Denmark
*
*Corresponding author: Email vik@ssi.dk
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Objective:

As a means to prevent neural tube defects (NTDs), women planning pregnancy in Denmark are recommended to take a dietary supplement of 400 μg folic acid daily during the periconceptional period. We examined compliance with this recommendation in a national survey.

Design:

Cohort study on pregnant women in Denmark.

Setting:

The Danish National Birth Cohort (DNBC).

Subjects:

From November 2000 to February 2002, 22 000 pregnant women were recruited for DNBC. Use of dietary supplements was recorded at enrolment. Compliance with the recommendation was related to an information campaign that took place during the second half of 2001, and to lifestyle factors provided in a telephone interview by the end of the first trimester of pregnancy.

Results:

An increase was seen in the proportion of women complying with the recommendation in the study period and this coincided with the information campaign events. However, even at the end of the period, only 22.3% of the women who had planned their pregnancy fully complied with the recommendation. No increase at all was seen in periconceptional folic acid use among women with unplanned pregnancies. Young age, low education and smoking were identified as factors that determined non-compliance.

Conclusions:

Alternative and more effective strategies are needed if the Danish population is to benefit fully from the knowledge that folic acid prevents NTDs. Future strategies should not only target vulnerable groups, such as the less educated and the young, but also women who get pregnant without planning this. The only possible way to reach the last group may be through fortification of foods with folic acid.

Type
Research Article
Copyright
Copyright © The Authors 2004

References

1MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the MRC Vitamin Study. Lancet 1991; 338: 132–7.Google Scholar
2Czeizel, AE, Dudas, I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. New England Journal of Medicine 1992; 327: 1832–5.CrossRefGoogle ScholarPubMed
3Berry, RJ, Li, Z, Erickson, JD, Li, S, Moore, CA, Wang, H, et al. Prevention of neural-tube defects with folic acid in China. China–US Collaborative Project for Neural Tube Defect Prevention. New England Journal of Medicine 1999; 341: 1485–90.CrossRefGoogle Scholar
4Botto, LD, Moore, CA, Khoury, MJ, Erickson, JD. Neural-tube defects. New England Journal of Medicine 1999; 341: 1509–19.CrossRefGoogle ScholarPubMed
5Mills, JL. Fortification of foods with folic acid – how much is enough? New England Journal of Medicine 2000; 342: 1442–5.CrossRefGoogle Scholar
6Wald, NJ, Law, MR, Morris, JK, Wald, DS. Quantifying the effect of folic acid. Lancet 2001; 358: 2069–73.CrossRefGoogle ScholarPubMed
7Department of Health. Folic Acid and The Prevention of Disease. Report on Health and Social Subjects No. 50. London: The Stationery Office, 2000.Google Scholar
8McDonnell, R, Johnson, Z, Doyle, A, Sayers, G. Determinants of folic acid knowledge and use among antenatal women. Journal of Public Health Medicine 1999; 21: 145–9.CrossRefGoogle ScholarPubMed
9McGovern, E, Moss, H, Grewal, G, Taylor, A, Bjornsson, S, Pell, J. Factors affecting the use of folic acid supplements in pregnant women in Glasgow. British Journal of General Practice 1997; 47: 635–7.Google ScholarPubMed
10The Gallup Organization for March of Dimes Birth Defects Foundation. Folic Acid and The Prevention of Birth Defects. Report 31–1596–01. New York: March of Dimes Birth Defects Foundation, 2001, 159.Google Scholar
11Van der Pal-de Bruin, KM, De Walle, HE, Jeeninga, W, de Rover, C, Cornel, MC, de Jong-van den Berg, LT, et al. The Dutch 'Folic Acid Campaign' – have the goals been achieved? Paediatric and Perinatal Epidemiology 2000; 14: 111–7.CrossRefGoogle ScholarPubMed
12Chan, A, Pickering, J, Haan, E, Netting, M, Burford, A, Johnson, A, et al. ‘Folate before pregnancy’: the impact on women and health professionals of a population-based health promotion campaign in South Australia. Medical Journal of Australia 2001; 174: 631–6.CrossRefGoogle ScholarPubMed
13Rasmussen, LB, Andersen, NL, Andersson, G, Lange, AP, Rasmussen, K, Skak-Iversen, L, et al. Folate and neural tube defects. Recommendations from a Danish working group. Danish Medical Bulletin 1998; 45: 213–7.Google ScholarPubMed
14Olsen, J, Melbye, M, Olsen, SF, Sorensen, TI, Aaby, P, Andersen, AM, et al. The Danish National Birth Cohort – its background, structure and aim. Scandinavian Journal of Public Health 2001; 29: 300–7.CrossRefGoogle ScholarPubMed
15Page, ES. Continuous inspection schemes. Biometrica 1954; 41: 100–14.CrossRefGoogle Scholar
16Shewhart, WA. Economic Control of Quality of Manufactured Product. New York: Van Nostrand-Reinhold, 1931.Google Scholar
17Braekke, K, Staff, AC. Periconceptional use of folic acid supplements in Oslo. Acta Obstetrica et Gynecologica Scandinavica 2003; 82: 620–7.CrossRefGoogle ScholarPubMed